Delivery Order SPE2DB20D3505-SPE2DB22FT3E7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,020.03, is for the delivery of 4,563,324,213 units of the pharmaceutical drug Nateglinide 120 mg tablets in 100-count bottles. The award has an ultimate completion date of January 16, 2024 and is a Firm Fixed Price Delivery Order contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the supply of 4,567,074 units of Nateglinide 120 mg tablets to the agency. The contract has a total ceiling value of $15,880.84 and is a firm fixed-price arrangement. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,037.49 firm fixed-price delivery order is for the supply of 4,566,825,872 units of the drug Nateglinide 120 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nateglinide 60 mg tablets. The contract has a ceiling value of $4,166.99 and runs through April 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, SPE2DB20D3505|SPE2DB25FU2J5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,925.63 firm fixed-price delivery order is for the supply of 4,567,648,830 units of the drug Nateglinide 60 mg Tablet. The contract has a completion date of March 21, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nateglinide 120 mg tablets in quantities of 100 on August 5, 2025, with completion targeted for August 6, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $1,573.16 and operates under firm fixed price terms. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the awardee location....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,133.05 firm-fixed-price delivery order is for the supply of Nateglinide 60 mg Tablet unit doses, with a completion date of September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery vehicles (IDVs) to provide a wide range of medical commodities,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,711,486 units of Nateglinide 60 mg Tablets in 100-count packages, with a ceiling value of $4,803.26. The contract is a firm fixed-price delivery order, with a period of performance ending on July 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,691.97 delivery order to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets in quantities of 100 units. This competitive award, issued on October 30, 2025, represents a firm fixed-price contract with an ultimate completion date of October 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competitively solicited and...
- The Defense Logistics Agency awarded a delivery order valued at $10,181.29 to AmerisourceBergen Drug Corp for the supply of Nateglinide 60 mg tablets (100-count units) with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT3E7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,082.79, is for the delivery of Nateglinide 120 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp plays a critical role in supplying essential medical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/15/21 |